Internationally-recognized tuberculosis expert Philip Hopewell, MD, reflects on the impact of funding cuts on TB research and infections both in the U.S. and abroad. Eddie Qian, MD, hosts. Dr. Qian is also co-host of the ICU Ed and Todd-cast podcast.

06:47 Why Kansas?
09:13 How does TB infection rates compare to HIV globally?
14:48 What are new guidelines for TB treatment?

Resources:
Updates on Treatment for Drug-Susceptible and Drug-Resistant Tuberculosis:  An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://www.atsjournals.org/doi/full/10.1164/rccm.202410-2096ST

Learn more: 
WHO Global TB Report
https://www.who.int/publications/i/item/9789240101531#:~:text=Overview,years%20can%20be%20found%20here.

The Black Angels by Maria Smilios
Everything is Tuberculosis by John Green

This episode dives into lessons learned from the ATS Vaccine Initiative with Robert Stansbury, MD, ATSF, the West Virginia University Medicine vaccine project lead. Dr. Stansbury talks about vaccine uptake in the rural population as compared to urban areas. Joining him is Dona Upson, MD, of the University of New Mexico, and a member of the ATS Vaccine Initiative Advisory Council. Dr. Upson shares how she broaches the subject of vaccination with her patients. 

06:45 - What are key takeaways from the ATS Vaccine Initiative?
09:39 - What motivates patients to get vaccinated?
13:07 -   How soon in the visit do you raise the subject of vaccination?

M. Patricia Rivera, MD, ATSF, immediate past-president of the American Thoracic Society and lung cancer expert, offers up a compelling argument for trusting science. As we're buffeted by government actions and disease outbreaks, it is critical that clinicians and public health officials work together to minimize the impact. Patti Tripathi hosts.

06:46 What is immune amnesia and how does it relate to measles?
08:51 What is the role of federal health agencies?
10:07 What is the ripple effect generated by research funding?
12:36 Why should the public trust science?

In this episode of ATS Breathe Easy, host Patti Tripathi welcomes two leading experts to discuss the critical role of vaccines in protecting children and high-risk populations. Paul Offit, MD, renowned scientist and vaccine advocate, and Tina Hartert, MD, MPH, professor of medicine and director of the Center for Asthma Research, provide an in-depth look at vaccine policies, hesitancy, and the consequences of declining immunization rates.

ATS Scholar editor Nitin Seam, MD, ATSF - clinical professor of Medicine at George Washington University and the Uniformed Services University - shares some takeaways from his editorial on the ATS journals' position on the evolving role of artificial intelligence on scientific research and review. Eddie Qian, MD, of Vanderbilt University Medical Center, hosts.

06:35 - What are the main takeaways of the ATS editorial?
09:13 - Should large language models be authors?
09:59 - Why would a reviewer want to upload a paper to an LLM?
21:08 - What are topics around AI and LLMs that should be studied in medicine?

Read the editorial in the American Journal of Respiratory and Critical Care Medicine:  https://www.atsjournals.org/doi/full/10.1164/rccm.202411-2208ED

Amy Attaway, MD, hosts the latest ATS Breathe Easy episode with former ATS President Monica Kraft, MD, and Asthma and Allergy Network's Chief Research Officer, De De Gardner, DrPH, discuss the benefits and challenges of biologics for asthma. What factors guide selection of a specific biologic for asthma? When should a patient transition from one biologic to another? 

08:15 What does shared decision making mean?
09:12 How often does a patient need to take a biologic? 
12:58 What if you need to renew your biologic but you've stopped taking your inhaler?
21:53 What's a strategy for combining biologics for asthma?

Self-described pulmonary fibrosis warrior and former journalist, Teresa Barnes, joins host and former CNN news anchor Patti Tripathi for the premiere episode of ATS Breathe Easy, the Latest. Ms. Barnes is chief executive of Pulmonary Fibrosis Warriors and former chair of the ATS Public Advisory Roundtable. PAR is comprised of 12-15 executives of respiratory-related patient interest organizations like the Pulmonary Fibrosis Warriors. 

Resources provided by podcast participants:

National Lung Cancer Round Table-https://nlcrt.org/

Lung Plan- https://nlcrt.org/lungplan-overview/

Standing Facility Lung Program-https://cancer.wvumedicine.org/about-us/programs/lung-cancer-screening-program

Mobile Lung Program- https://cancer.wvumedicine.org/about-us/programs/mobile-cancer-screening-program/lucas

Living Beyond Cancer Podcast Series(Patient, Survivors, and Caregivers)-https://cancer.wvumedicine.org/about-us/podcasts/

Lung cancer care begins with prevention. This podcast aims to provide expert insights and practical advice on quitting smoking. We explore the opt-out approach, an effective strategy for initiating conversations about quitting smoking, and provide a comprehensive overview of pharmacotherapy options available to support the patients through their smoking cessation journey. Tune in as we tackle common questions and concerns faced by patients, offering practical tips and guidance to help you kick the habit for good.

Disclosures: no financial interests in the production of this material

A practical case-based approach to the management setting and titrating the ventilator in ARDS